Close

Analyst Ratings for Altimmune (ALT)

ALT Rating Summary

ALT Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ALT
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $16.25 (+114.7%) * Over Last 12-Mos
Rating Score: 9 / 10   Percentile Rank: 90%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/24/2024 Goldman Sachs Corinne Jenkins New Coverage Neutral
(N/A)
13.00
(N/A)
10.04
(7.57)
-24.6% Details
12/29/2021 Jefferies
» Updated 8/31/2022
Roger Song New Coverage Buy
(N/A)
35.00
(30.00)
8.84
(7.57)
-14.37% Details